Can an herbal agent replace estrogen for hot flashes?

Cancer Investigation

Volumn 22, Issue 4, 2004, Pages 645-647

  Jacobson, Judith S ^a   Grann, Victor R ^a,b  

^a Herbert Irving Compreh Cancer Ctr ^*  (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; ESTROGEN; FORMONONETIN; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BREAST CANCER; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; ESTROGEN ACTIVITY; FRACTURE; HOT FLUSH; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE;

CIMICIFUGA; CONTROLLED CLINICAL TRIALS; ESTROGENS; FEMALE; HOT FLASHES; HUMANS; PLANT EXTRACTS; PLANT PREPARATIONS;

EID: 8644232386     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-200027171     Document Type: Editorial

References (20)

1. Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; Kotchen, J.M.; Ockene, J. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 Jul 17, 288(3), 321-333.
2. Hays, J.; Ockene, J.K.; Brunner, R.L.; Kotchen, J.M.; Manson, J.E.; Patterson, R.E.; Aragaki, A.K.; Shumaker, S.A.; Brzyski, R.G.; LaCroix, A.Z.; Granek, I.A.; Valanis, E.G. Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 2003 Mar 17, 348, 1839-1854.
3. Goldberg, R.M.; Loprinzi, C.L.; O'Fallon, J.R.; Veeder, M.H.; Miser, A.W.; Mailliard, J.A.; Michalak, J.C.; Dose, A.M.; Rowland, K.M., Jr; Burnham, N.L. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J. Clin. Oncol. 1994, 12, 155-158.
4. Loprinzi, C.L.; Michalak, J.C.; Quella, S.K.; O'Fallon, J.R.; Hatfield, A.K.; Nelimark, R.A.; Dose, A.M.; Fischer, T.; Johnson, C.; Klatt, N.B.; Bate, W.W.; Respond, R.M.; Oesterling, J.E. Megestrol acetate for the prevention of hot flashes. N. Engl. J. Med. 1994, 331, 347-352.
5. Loprinzi, C.L.; Pisansky, T.M.; Fonseca, R.; Sloan, J.A.; Zahasky, K.M.; Quella, S.K.; Novotny, P.J.; Rummans, T.A.; Dumesic, D.A.; Perez, E.A. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J. Clin. Oncol. 1998, 16, 2377-2381.
6. Loprinzi, C.L.; Kugler, J.W.; Sloan, J.A.; Mailliard, J.A.; LaVasseur, B.I.; Barton, D.L.; Novotny, P.J.; Dakhil, S.R.; Rodger, K.; Rummans, T.A.; Christensen, B.J. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000, 356, 2059-2063.
7. Loprinzi, C.L.; Sloan, J.A.; Perez, E.A.; Quella, S.K.; Stella, P.J.; Mailliard, J.A.; Halyard, M.Y.; Pruthi, S.; Novotny, P.J.; Rummans, T.A. Phase III evaluation of fluoxetine for treatment of hot flashes. J. Clin. Oncol. 2002, 20, 1578-1583.
8. Stearns, V.; Isaacs, C.; Rowland, J.; Crawford, J.; Ellis, M.J.; Kramer, R.; Lawrence, W.; Hanfelt, J.J.; Hayes, D.F. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann. Oncol. 2000, 11, 17-22.
9. Barton, D.L.; Loprinzi, C.L.; Quella, S.K.; Sloan, J.A.; Veeder, M.H.; Egner, J.R.; Fidler, P.; Stella, P.J.; Swan, D.K.; Vaught, N.L.; Novotny, P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J. Clin. Oncol. 1998, 16, 495-500.
10. Quella, S.K.; Loprinzi, C.L.; Barton, D.L.; Knost, J.A.; Sloan, J.A.; LaVasseur, B.I.; Swan, D.; Krupp, K.R.; Miller, K.D.; Novotny, P.J. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J. Clin. Oncol. 2000, 18, 1068-1074.
11. Wade, C.; Kronenberg, F.; Kelly, A.; Murphy, P.A. Hormone-modulating herbs: implications for women's health. J. Am. Med. Women's Assoc. 1999, 54, 181-183.
12. Liske, E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disorders. Adv. Ther. 1998, 15, 45-53.
13. Pepping, J. Black cohosh: Cimicifuga racemosa. Am. J. Health-Syst. Pharm. 1999, 56, 1400-1402.
14. Lieberman, S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J. Women's Health 1998, 7, 525-529.
15. Pockaj, B.A.; Loprinzi, C.L.; Sloan, J.A.; Novotny, P.J.; Barton, D.L.; Hagenmaier, A.; Zhang, H.; Lambert, G.H.; Reeser, K.A.; Wisbey, J.A. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Investig. in press.
16. Jacobson, J.S.; Troxel, A.B.; Evans, J.; Klaus, L.; Vahdat, L.; Kinne, D.; Lo, K.M.; Moore, A.; Rosenman, P.J.; Kaufman, E.L.; Neugut, A.I.; Grann, V.R. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J. Clin. Oncol. 2001, 19, 2739-2745.
17. Liu, J.; Burdette, J.E.; Xu, H.; Gu, C.; van Breemen, R.B.; Bhat, K.P.; Booth, N.; Constantinou, A.I.; Pezzuto, J.M.; Fong, H.H.; Farnsworth, N.R.; Bolton, J.L. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J. Agric. Food Chem. 2001, 49, 2472-2479.
18. Kennelly, E.J.; Baggett, S.; Nuntanakorn, P.; Ososki, A.L.; Mori, S.A.; Duke, J.; Coleton, M.; Kronenberg, F. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine 2002 Jul, 9(5), 461-467.
19. White, J. PC-SPES - a lesson for future dietary supplement research. J. Natl. Cancer Inst. 2002, 94, 1261-1263.
20. Blumenthal, M. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medications; American Botanical Council: Austin, 1998; 90.